Dollar General, rue21 to price IPOs this week
Middle East North Africa - Financial Network

Demand More is a registered trade mark of MENAFN.COM

 
GFT_ldr_Feb4
 
  Quotes: US MENA   Enter Symbol: NewsLetter: Search News: advanced
 Home  |  MENAFN News  |  Global News RELATED: Global News Regional News News Search

Dollar General, rue21 to price IPOs this week  Join our daily free Newsletter

MarketWatch.com-Sunday, November 08, 2009
Digg This Article: Dollar General, rue21 to price IPOs this week Share This Article: Dollar General, rue21 to price IPOs this week Add to Delicious Seed this article Buzz this article Add to Reddit Add to furl Add to stumbleupon Add to Mixx!

Dollar General, rue21 IPOs offer investors value deals

Last Update: 2:13 PM ET Nov 8, 2009

SAN FRANCISCO (MarketWatch) -- Dollar General Corp., a discount chain controlled by a Kohlberg Kravis Roberts & Co. unit, and teen-apparel retailer rue21, inc. are expected to make their initial public offerings late this week.

The deals, worth a combined $865.2 million if they sell at the middle of their anticipated ranges, will be a fresh test of investor appetite for shares in retail companies that focus on value.

"This week's IPOs are both long awaited," said Scott Sweet, senior managing partner at advisory firm IPO Boutique. Checks of brokerage channels suggest "interest will be high on both," he said via email.

Dollar General is expected to sell 34.1 million shares between $21 and $23 each under the symbol "DG" on the New York Stock Exchange. Pricing is likely Thursday, with a sale Friday.

Proceeds from the deal, worth up to $784 million, will go to reduce debt, Dollar General has said in securities filings.

The Goodlettsville, Tenn.-based company is the largest discount retailer in the U.S. by number of stores, with 8,577 in 35 states as of July 31. It sells products usually priced at $10 or less and had $10.5 billion in total sales for its year ended Jan. 30.

Private-equity firm KKR bought Dollar General in 2007 for $7.2 billion. If its IPO shares sell at the midpoint of the expected range, its market value will top that price, at $7.67 billion, according to Renaissance Capital.

Also late next week, rue21 is planning to raise up to $122 million by selling 6.77 million shares for $16 to $18 each under the ticker "rue." Shares are expected to start trading Friday, says IPO Boutique.

The Warrendale, Penn.-based.. company, with 502 stores in 43 states, focuses on trendy apparel for teens at moderate prices.

After the IPO sale, private equity firm Apax Partners will own nearly 58% of rue21's common stock.

The Dollar General and rue21deals will add to the 47 IPOs that have priced in the U.S. this year, according to Renaissance Capital. That's up 12% from last year.

Retail stocks were hard hit at the height of the credit crisis but have come roaring back in recent months.

The S&P 500 retail index RLX has gained 42% this year, topping the broader S&P 500's $SPX 18% gain.

Shares of ultravalue discount stores like Dollar Tree Inc. DLTR outperformed the broad market late last year as investors bet high unemployment and shrinking credit would push more households to shop at these chains.

Those gains have moderated this year. Dollar Tree's shares have gained about 17%. Family Dollar Stores Inc. FDO shares have gained 10%.

Citigroup Inc. C, Goldman Sachs & Co. GS, KKR, Bank of America-Merrill Lynch BAC and J.P. Morgan Chase & Co. JPMare joint book-running managers for the Dollar General IPO.

For rue21, the lead managers are Bank of America-Merrill Lynch, Goldman and J.P. Morgan.



International Provider
Feb 09, 2010 ECB flight change boosts Greek rescue speculation, MarketWatch.com
Analysts say news Tuesday that the European Central Bank president will return early from Australia to attend a meeting of European Union leaders in Brussels is providing the euro and financial markets with a lift.
Feb 09, 2010 Drug stocks gain; Cell Therapeutics rebounds, MarketWatch.com
Drug stocks gain in early action while shares of Cell Therapeutics bounced back after diving almost 25% on Monday over concerns about its new non-Hodgkin's lymphoma treatment pixantrone.
Feb 09, 2010 Europe stocks buoyed by rescue hopes for Greece, MarketWatch.com
Stocks in Europe trade mixed-to-slightly higher as worries about Greece's finances appear to abate and as earnings news is eyed.
Feb 09, 2010 Updates, advisories and surprises, MarketWatch.com
A roundup of the latest corporate earnings reports and what companies are saying about future quarters.
Feb 09, 2010 Financial stocks rise as Europe worries moderate, MarketWatch.com
Earnings reports buoy investor spirits dampened over the last several days by worry about turmoil in European economies.
Feb 09, 2010 NYSE Euronext rallies after profit tops forecasts, MarketWatch.com
The stock-exchange operator NYSE Euronext avoids the impairment charges that weighed on its results a year earlier as its profit tops estimates.
Feb 09, 2010 Pulte sees smaller loss after charges, tax gains, MarketWatch.com
The home-building giant that acquired Centex last year narrows its fourth-quarter loss as its bottom line is hit by charges of more than $900 million.
Feb 09, 2010 U.S. futures recover after sub-10,000 Dow close, MarketWatch.com
U.S. stock futures are stronger Tuesday, recovering after the Dow Jones Industrial Average finished below the 10,000 mark for the first time since early November.
Feb 09, 2010 U.S. futures recover after sub-10,000 Dow close, MarketWatch.com
U.S. stock futures are stronger Tuesday, recovering after the Dow Jones Industrial Average finished below the 10,000 mark for the first time since early November.
Feb 09, 2010 UBS swings to profit, but outflows accelerate, MarketWatch.com
Fourth-quarter profit at UBS is helped by lower costs and a tax credit, though the outflow of client money from its wealth-management arm accelerates.
more...

GFCMarkets


GFT_Square_Feb1
Google
Terms of Service  |   Privacy Policy  |   Contact Us |   Advertise  |   About MENAFN  |   Career Opportunities  |   Feedback
Copyright ©2000 All Rights Reserved.